A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1997
12/02/1997	US5693343 Mixing acetonitrile solutions of antigen-sucrose matrix and glycolide-lactide copolymer, then emulsification with an oil and centrifuging yields microspheres containing encapsulated antigen for orally administered vaccines
12/02/1997	US5693326 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
12/02/1997	US5693325 Peptide vaccines and methods relating thereto
12/02/1997	US5693322 Using antibodies that can cross-associate with antibodies on other cells to bring the cells into proximity with one another
11/1997
11/30/1997	CA2206575A1 Live attenuated rtx-producing bacteria of the family pasteurellaceae
11/27/1997	WO1997044668A1 Early detection of lysosomal storage disorders
11/27/1997	WO1997044493A1 Anti-paramyxovirus screening method and vaccine
11/27/1997	WO1997044487A1 Method and probes for the identification of microbial genes specifically induced during host infection
11/27/1997	WO1997044468A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF
11/27/1997	WO1997044463A2 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin
11/27/1997	WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
11/27/1997	WO1997044460A1 Modulators of tissue regeneration
11/27/1997	WO1997044453A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997	WO1997044451A2 Vasoactive amine binding molecules
11/27/1997	WO1997044445A1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents
11/27/1997	WO1997044441A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/27/1997	WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
11/27/1997	WO1997044352A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	WO1997044349A1 BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
11/27/1997	WO1997044060A1 Passively administered antibody that enhances feed conversion efficiency
11/27/1997	WO1997043901A1 IceA GENE AND RELATED METHODS
11/27/1997	WO1997035976A3 Epidermal differentiation factor
11/27/1997	WO1997032572A3 Materials and methods for enhancing cellular internalization
11/27/1997	DE19629938C1 Monoclonal antibodies specific for mutated E-Cadherin peptide sequences
11/27/1997	CA2804657A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997	CA2731490A1 Early detection of lysosomal storage disorders
11/27/1997	CA2496906A1 Ret ligand (retl) for stimulating neural and renal growth
11/27/1997	CA2256465A1 Blocking expression of virulence factors in s. aureus
11/27/1997	CA2255906A1 Human interleukin-1j and antagonists thereof
11/27/1997	CA2255888A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	CA2255706A1 Method and probes for the identification of microbial genes specifically induced during host infection
11/27/1997	CA2227171A1 Icea gene and related methods
11/26/1997	EP0808899A2 Human marco scavenger receptor (HMarcoSR)
11/26/1997	EP0808897A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/26/1997	EP0808846A2 Peptides which react with antiboby representing the prognostic marker for HIV disease progression
11/26/1997	EP0808369A1 GnRH-LEUKOTOXIN CHIMERAS
11/26/1997	EP0808367A1 Mucosal vascular addressins and uses thereof
11/26/1997	EP0808366A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF
11/26/1997	EP0808365A1 Human interleukin-1 receptor accessory protein
11/26/1997	EP0808362A1 Herpes simplex virus mutants
11/26/1997	EP0808361A1 Novel replication process
11/26/1997	EP0808173A2 Product and method for preventing respiratory virus infection
11/26/1997	EP0662130B1 A method of producing hepatocyte growth factor and a cell line
11/26/1997	EP0464096B1 Method of preparing vaccines
11/26/1997	CN1036522C Improved meningococcal polysaccharide conjugate vaccine
11/26/1997	CN1036504C Improved meningococoal polysaccharide conjugate vaccine prepn. method
11/25/1997	US5691449 Respiratory syncytial virus vaccines
11/25/1997	US5691448 Glutamic acid decarboxylase protein for autoantibody binding to epitopes
11/25/1997	US5691306 Protein secretion
11/25/1997	US5691301 Nisin compositions for use as enhanced, broad range bactericides
11/25/1997	US5691186 Filariid cysteine protease genes
11/25/1997	US5691183 CD4+ T-lymphoctye proteases and genes encoding said proteases
11/25/1997	US5691177 Lymphocytes and genetic vectors for treatment of cancer or autoimmune diseases
11/25/1997	US5691170 Generation of hybrid genes and proteins by virus-mediated recombination
11/25/1997	US5691167 DNA encoding allergenic proteins and peptides from Johnson grass pollen
11/25/1997	US5691155 Detectors, vectors, gene expression
11/25/1997	US5690942 Adjuvants for viral vaccines
11/25/1997	US5690941 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes
11/25/1997	US5690940 Low pathogencity PRRS live virus vaccines and methods of preparation thereof
11/25/1997	US5690939 Immunizing poultry
11/25/1997	US5690938 Oral immunization with multiple particulate antigen delivery system
11/25/1997	US5690937 Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
11/25/1997	US5690934 Peptides relating to the extracellular membrane-bound segment of human alpha chain
11/25/1997	CA2099865C Hepatic growth factor receptor is the met proto-oncogene
11/25/1997	CA1339557C Cell sorting technique and applications thereof
11/22/1997	CA2205077A1 Peptides which react with antibody representing the prognostic marker for hiv disease progression
11/20/1997	WO1997043649A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿
11/20/1997	WO1997043428A1 Transgenic plants expressing rabies glycoprotein g, and glycoproteins thus obtained
11/20/1997	WO1997043420A1 Method for identifying attenuated chickenpox virus oka strain or strain originating therein and acceptable as attenuated chickenpox vaccine virus
11/20/1997	WO1997043417A1 Cortistatin: neuropeptides, compositions and methods
11/20/1997	WO1997043416A1 Common gamma chain blocking agents
11/20/1997	WO1997043408A1 Anti-human mp52 monoclonal antibody
11/20/1997	WO1997043405A1 UDP-N-ACETYL-α-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE, GalNAc-T3
11/20/1997	WO1997043314A2 Collagen binding protein compositions and methods of use
11/20/1997	WO1997043309A1 Tsetse thrombin inhibitor
11/20/1997	WO1997043304A1 Novel compounds
11/20/1997	WO1997043303A1 Novel compounds
11/20/1997	WO1997042980A1 Methods of terminal sterilization of biological products
11/20/1997	WO1997042973A1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response
11/20/1997	WO1997042972A1 Attenuated canine parvovirus vaccine
11/20/1997	WO1997042971A1 Recombinant neospora antigens and their uses
11/20/1997	WO1997042968A2 Administration of histamine for therapeutic purposes
11/20/1997	WO1997042947A1 Methods of treating type i hypersensitivity using monophosphoryl lipid a
11/20/1997	WO1997038711A3 T-cell dependent vaccine and the cell surface receptor cd28
11/20/1997	CA2255669A1 Collagen binding protein compositions and methods of use
11/20/1997	CA2254857A1 Anti-human mp52 monoclonal antibody
11/20/1997	CA2254783A1 Cortistatin: neuropeptides, compositions and methods
11/20/1997	CA2254115A1 Transgenic plants expressing rabies glycoprotein g, and glycoproteins thus obtained
11/20/1997	CA2253942A1 Common gamma chain blocking agents
11/20/1997	CA2253851A1 Tsetse thrombin inhibitor
11/20/1997	CA2253602A1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response
11/20/1997	CA2253365A1 Administration of histamine for therapeutic purposes
11/20/1997	CA2251547A1 Recombinant neospora antigens and their uses
11/19/1997	EP0807686A2 Interleukin-1 beta converting enzyme like apoptotic protease-7
11/19/1997	EP0807683A2 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/19/1997	EP0807183A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
11/19/1997	EP0807178A1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
11/19/1997	EP0807176A2 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
11/19/1997	EP0807166A1 A method of preparing an undifferentiated cell
11/19/1997	EP0807125A2 Monoclonal antibodies anti-cd6 and their uses

1 ... 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 ... 1823